Yüklüyor......
Resiquimod enhances mucosal and systemic immunity against avian infectious bronchitis virus vaccine in the chicken
Adjuvant enhancing mucosal immune response is preferred in controlling many pathogens at the portal of entry. Earlier, we reported that a toll-like-receptor 7 (TLR7) agonist, resiquimod (R-848), stimulated the systemic immunity when adjuvanted with the inactivated Newcastle disease virus vaccine in...
Kaydedildi:
| Yayımlandı: | Microb Pathog |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier Ltd.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7127065/ https://ncbi.nlm.nih.gov/pubmed/29635053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.micpath.2018.04.012 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|